Source: http://www.prnewswire.com/news-releases/mei-pharmas-mitochondrial-inhibitor-drug-candidate-me-344-delays-tumor-growth-in-recurrent-ovarian-cancer-model-202383981.html
click here website
No comments:
Post a Comment